Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06486636 · ClinicalTrials.gov registry record · NA
Pericardiotomy in Cardiac Surgery
A NA study of Atrial Fibrillation and Atrial Flutter, sponsored by Population Health Research Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 1,400
- Enrollment target
- 4
- Study locations
NCT06486636: Recruiting NA study of Atrial Fibrillation and Atrial Flutter, sponsored by Population Health Research Institute.
NCT06486636 is a NA study of Atrial Fibrillation and Atrial Flutter that is actively recruiting participants, run by Population Health Research Institute. The registered enrollment target is 1,400 participants, below the 2,990-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (53% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06486636, a NA study of Atrial Fibrillation and Atrial Flutter, is actively recruiting participants, sponsored by Population Health Research Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,400 participants
- Enrollment target
- 4
- Study locations
Study Summary
PRINCE is an international, multicentre, randomized controlled trial of posterior pericardiotomy in patients without a history of atrial fibrillation (AF) or flutter undergoing cardiac surgery.
Primary Outcome
Number of patients with post-operative atrial fibrillation within the first 5 days postoperatively or up to hospital discharge, whichever occurs first
Conditions Studied
Interventions
- PROCEDURE Left Posterior Pericardiotomy
Study Locations (4)
New York
- Weill Cornell Medicine - New York
Vienna
- Medical University Vienna - Vienna
Ontario
- Hamilton Health Sciences - Hamilton
Foggia
- University of Foggia, Policlinico Foggia - Foggia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,400 participants |
| Start Date | 2024-10-21 |
| Est. Completion | 2031-09-01 |
| Phase | NA |
What NCT06486636 shows while recruiting
NCT06486636 is an interventional study that assigns participants to a tested intervention. Its 1,400 participants enrollment target places it among the larger protocols in the corpus, below the 2,990-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (53% lower).
The record links to 3 conditions, with Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which Left Posterior Pericardiotomy is the first listed.
NCT06486636 reports a single indexed study location in New York, Vienna, Ontario.
Frequently Asked Questions
What is clinical trial NCT06486636 about?
NCT06486636 is a clinical study titled "Pericardiotomy in Cardiac Surgery". PRINCE is an international, multicentre, randomized controlled trial of posterior pericardiotomy in patients without a history of atrial fibrillation (AF) or flutter undergoing cardiac surgery.
What is the current status of trial NCT06486636?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,400 participants. The study started on 2024-10-21. Estimated completion is 2031-09-01.
What conditions does trial NCT06486636 study?
This clinical trial studies the following conditions: Atrial Fibrillation, Atrial Flutter, Cardiac Events.
What interventions are being tested in trial NCT06486636?
The interventions under investigation include: Left Posterior Pericardiotomy (PROCEDURE).
Who is sponsoring clinical trial NCT06486636?
This trial is sponsored by Population Health Research Institute, which has 21 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06486636 being conducted?
This trial has 4 study locations across New York, Vienna, Ontario, Foggia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06486636's enrollment target sits among peer trials
1,400 34th of 202 higher than 169 of 202 other Atrial Fibrillation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Atrial Fibrillation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Renal Denervation + PVI vs PVI Alone for Persistent AF
RECRUITING · NA
-
CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation
RECRUITING · NA
-
The CONFORM Pivotal Trial
RECRUITING · NA
-
Vascular Closure With a Device Compared to Manual Compression After Atrial Fibrillation Ablation: The LockeT II Study
RECRUITING · NA
-
The Fourth Left Atrial Appendage Occlusion Study
RECRUITING · NA
-
Exercise Activity Intervention With Sensor-Based Engagement in Patients With Atrial Fibrillation
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02205762 · 1,400 participants · Phase 2
LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis
- NCT02445222 · 1,400 participants · Phase 3
CAR-T Long Term Follow Up (LTFU) Study
- NCT03145077 · 1,400 participants · NA
Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Diagnosing Osteoradionecrosis in Patients With Head and Neck Cancer That Is Primary, Has Come Back, or Has Spread to Other Places in the Body
- NCT04250857 · 1,400 participants
HeartStart FRx Defibrillator Event Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI